πŸ‡ΊπŸ‡Έ FDA
Patent

US 9840559

Anti-CD83 antibodies and use thereof

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 9840559 (Anti-CD83 antibodies and use thereof) held by The Regents of the University of California expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2039/545, A61P, A61P37/06